GEROSCIENCE TRANSLATIONAL CLINICAL TRIALS /
ICFSR (FRAILTY AND SARCOPENIA) TASK FORCE
Translational Research on Mitochondria Aging Muscle, Sarcopenia and Frailty: from Biological Assessment to Drug Development
&
Patient-Reported Outcomes in Frailty and Sarcopenia
DISCOVER THE PRELIMINARY PROGRAM HERE
The Task Force is open to additional communications; if you have any interest in presenting your work, please submit your abstract along with your CV as soon as possible and before January 4, 2024 by clicking HERE
This Task Force is limited to a small number of Key Opinion Leaders (maximum of 80 persons) from academy and industry to allow for productive discussions on the development of new drugs for healthy aging.